Lenvatinib in Metastatic DTC (Differentiated Thyroid Cancer)- A
Pragmatic Approach with Dosing
Arif Shaukat* and J Ansari
DOI: 10.26717/BJSTR.2017.01.000156
-
Author Information
Open or Close
- Prince Sultan Military Medical City Riyadh, Saudi Arabia
*Corresponding author:
Arif Adnan Shaukat, Prince Sultan Military Medical City Riyadh, KSA, Saudi Arabia
Received: June 18, 2017 Published: June 29, 2017
To view the Full Article Peer-reviewed Article PDF
Abstract
Keywords: Differentiated thyroid cancer (DTC); Lenvatinib; Multi kinase inhibitors; Metastatic; Radio iodine refractory
Abbreviations:
RR-DTC: Radio iodine refractory Differentiated Thyroid Cancers
Introduction |
Case 1 |
Case 2 |
Case 3 |
Discussion |
Conclusion |
References |
ISSN: 2574 -1241
